Quotient Sciences Quotient Sciences

X

CAS 101-39-3 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 101-39-3
Also known as: 101-39-3, Methylcinnamaldehyde, Z-alpha-methylcinnamaldehyde, 2-methyl-3-phenylacrylaldehyde, Alpha-methyl cinnamaldehyde, A-methyl cinnamaldehyde
Molecular Formula
C10H10O
Molecular Weight
146.19  g/mol
InChI Key
VLUMOWNVWOXZAU-UHFFFAOYSA-N

1 2D Structure

CAS 101-39-3

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-methyl-3-phenylprop-2-enal
2.1.2 InChI
InChI=1S/C10H10O/c1-9(8-11)7-10-5-3-2-4-6-10/h2-8H,1H3
2.1.3 InChI Key
VLUMOWNVWOXZAU-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC(=CC1=CC=CC=C1)C=O
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 101-39-3

2. Methylcinnamaldehyde

3. Z-alpha-methylcinnamaldehyde

4. 2-methyl-3-phenylacrylaldehyde

5. Alpha-methyl Cinnamaldehyde

6. A-methyl Cinnamaldehyde

7. .alpha.-methylcinnamaldehyde

8. (2e)-2-methyl-3-phenylprop-2-enal

9. 2-methyl-3-phenyl-prop-2-enal

10. Alpha-methyl-cinnamaldehyde

11. Dsstox_cid_5587

12. 2-methyl-3-phenyl-propenal

13. Dsstox_rid_77841

14. Dsstox_gsid_25587

15. Chembl3184118

16. Dtxsid4025587

17. 3-phenyl-2-methyl-prop-2-enal

18. Tox21_200051

19. Ncgc00257605-01

20. Cas-101-39-3

21. Ft-0622175

22. Ft-0656632

23. Ft-0695613

2.3 Create Date
2005-03-26
3 Chemical and Physical Properties
Molecular Weight 146.19 g/mol
Molecular Formula C10H10O
XLogP32.2
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count1
Rotatable Bond Count2
Exact Mass146.073164938 g/mol
Monoisotopic Mass146.073164938 g/mol
Topological Polar Surface Area17.1 Ų
Heavy Atom Count11
Formal Charge0
Complexity152
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count1
Covalently Bonded Unit Count1
Flag China
Digital Content Digital Content
URL Supplier Web Content
101-39-3
2-methyl cinnamic aldehyde
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY